FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

16152911000001101: Competact 15mg/850mg tablets (Lexon (UK) Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Dec 2009. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
57053101000001113 Competact 15mg/850mg tablets (Lexon (UK) Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
57053201000001118 Competact 15mg/850mg tablets (Lexon (UK) Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Competact 15mg/850mg tablets (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Competact 15mg/850mg tablets (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel Import - supplier (qualifier value) false Inferred relationship Existential restriction modifier
Competact 15mg/850mg tablets (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Competact 15mg/850mg tablets (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier
Competact 15mg/850mg tablets (Lexon (UK) Ltd) Is a Product containing precisely metformin hydrochloride 850 milligram and pioglitazone (as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Competact 15mg/850mg tablets (Lexon (UK) Ltd) Has active ingredient Metformin hydrochloride false Inferred relationship Existential restriction modifier
Competact 15mg/850mg tablets (Lexon (UK) Ltd) Has active ingredient Pioglitazone hydrochloride false Inferred relationship Existential restriction modifier
Competact 15mg/850mg tablets (Lexon (UK) Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Competact 15mg/850mg tablets (Lexon (UK) Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Competact 15mg/850mg tablets (Lexon (UK) Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Competact 15mg/850mg tablets (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Pioglitazone true Inferred relationship Existential restriction modifier
Competact 15mg/850mg tablets (Lexon (UK) Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Competact 15mg/850mg tablets (Lexon (UK) Ltd) Is a Competact true Inferred relationship Existential restriction modifier
Competact 15mg/850mg tablets (Lexon (UK) Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Competact 15mg/850mg tablets (Lexon (UK) Ltd) Has specific active ingredient Pioglitazone hydrochloride true Inferred relationship Existential restriction modifier
Competact 15mg/850mg tablets (Lexon (UK) Ltd) Has specific active ingredient Metformin hydrochloride true Inferred relationship Existential restriction modifier
Competact 15mg/850mg tablets (Lexon (UK) Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Competact 15mg/850mg tablets (Lexon (UK) Ltd) Has basis of strength substance Pioglitazone true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Competact 15mg/850mg tablets (Lexon (UK) Ltd) 56 tablet Has AMP True Competact 15mg/850mg tablets (Lexon (UK) Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start